Dana-Farber/Brigham And Women's Cancer Center Experts Webcast 10th Annual Patient Education Event On Prostate Cancer

�On September 10, 2008, at
6 p.m. E.T., leading prostate
genus Cancer specialists from
Dana-Farber/Brigham and Women's Cancer Center will webcast their 10th
Annual Symposium on Prostate Cancer, a patient education outcome
featuring the newest advances in discourse, screening, and prevention
of prostate crab.



For this webcast, Anthony V. D'Amico, MD, PhD, Chief of the Prostate
Cancer Radiation
Oncology Service, Philip W. Kantoff, MD, Director of
the Lank Center for Genitourinary Oncology, Jerome P. Richie, MD,
Chief of Urologic Surgery, and Jim C. Hu, MD, MPH, Director of
Minimally Invasive Urologic Oncology, will discourse the up-to-the-minute
approaches and research in the bar, diagnosis, and treatment
of prostate crab.



The Symposium will provide an overview of young treatment advances and
related outcomes, including new medical therapies, radioactive seed
implantation techniques, robotic-assisted surgery, nerve-sparing
techniques, image-guided radiation therapy approaches, and the to the highest degree
recent results of clinical trials. Also, the latest findings in the
genetic science of prostate cancer and prostate cancer screening guidelines
will be discussed.



The second most common crab in workforce, prostate genus Cancer is most often
diagnosed in workforce over the age of 50. The National Cancer Institute
estimates more than 186,000 new cases of prostate cancer in the
United States in 2008, and more than 28,000 deaths from the disease.
More common in African-American men than in Caucasian men, studies
have too shown that a man's risk is doubled if his sire or brother
has the disease.



Brigham and Women's Hospital (BWH) is a 777-bed not-for-profit teaching
affiliate of Harvard Medical School and a founding appendage of Partners
HealthCare, an integrated health care legal transfer network. In July of
2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular
Center, the most advanced center of its kind. BWH is committed to
excellency in patient role care with expertise in virtually every
specialty of medicine and surgery. The BWH medical preeminence dates
back to 1832, and today that rich history in clinical care is coupled
with its national leadership in quality melioration and patient
safety initiatives and its dedication to educating and training the
next generation of wellness care professionals. Through probe
and find conducted at its Biomedical Research Institute (BRI),
BWH is an international drawing card in basic, clinical and translational
research on human diseases, involving more than 860
physician-investigators and famed biomedical scientists and faculty
supported by more than $416 M in financial support. BWH is also home to major
landmark epidemiological population studies, including the Nurses' and
Physicians' Health Studies and the Women's Health Initiative. For
more information around BWH, please visit hTTP://www.brighamandwomens.org



To view a preview of this curriculum and learn more see OR-Live VNR: http://www.OR-Live.com



More info

• NASA completes Mars exploration
• Noodle ’staves off hunger pangs’
• Listeria fears grow after camp workers get sick
• Why Young Men Don’t Know How to Act
• The Most Common Problems of Men�s Health

Gibson and Glover to make Lethal Weapon 5?

Actors Mel Gibson and Danny Glover are reportedly ready to star in a fifth 'Lethal Weapon' movie.

Ten years after the release of the fourth instalment of the action franchise, both actors ar said to be in negotiations to reprise their roles as Riggs and Murtaugh for 'Lethal Weapon 5'.

Last year director Richard Donner revealed that he was ready to make another motion-picture show as long as Gibson signed up to the project. Donner directed all four former movies.

A source told the Daily Star: "Lethal Weapon 5 is a go. Mel and Danny ar back. The script is fabulous!"

More information

• Backworld
• Gordian Knot
• Ashit Desai
• The Cheese Band
• Blt